NCT04507126View on ClinicalTrials.gov

A Pilot Study of the Effects of BCG Immunization on CSF and Blood-based Biomarkers in Older Adults.

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

April 27, 2022

Study Completion Date

April 27, 2022

Conditions
Healthy
Interventions
BIOLOGICAL

Bacillus Calmette-Guerin (BCG)

Vaccine

Trial Locations (1)

02124

Clinical Translational Research Unit, Charlestown

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT04507126 - A Pilot Study of the Effects of BCG Immunization on CSF and Blood-based Biomarkers in Older Adults. | Biotech Hunter | Biotech Hunter